OpenAlex
PricingAboutJobs
Log inGet started
Work

Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy

HTML

Year: 2014
Type: review
Source: Journal of Oncology Pharmacy Practice
DOI: 10.1177/1078155214538087
Authors: Jing Lu, Linda Lee-Gabel, Michelle C Nadeau, Thomas M Ferencz, Scott A Soefje
Institutions: Yale University, Smilow Cancer Hospital, Seton Healthcare Family, University Medical Center Brackenridge
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: PD-1/PD-L1 pathway, cancer immunotherapy, immune checkpoint inhibitors, nivolumab, pembrolizumab, atezolizumab, durvalumab, CTLA-4 blockade, immune-related adverse events, immune-related pneumonitis, immune-related colitis, melanoma, renal cell carcinoma, non-small cell lung cancer, clinical efficacy and safety
SDG: Good health and well-being

Open Access status: closed

Funder: Mitsubishi Electric Research Laboratories
OpenAlex ID: W1979401452
FWCI: 2.401
Cites: 40
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security